The Concern Around Kratom ‘Drug Hysteria’?


A public backlash to the DEA’s announcement was swift and furious; citizens wrote to politicians, petitioned the White House, and talked to the media about what they saw as an infringement on their right to use a helpful plant.

Researchers expressed concern that the study of kratom’s potential medical uses could be crippled by the expensive and time-consuming regulatory hurdles that scientists must clear before studying Schedule I substances. In an unprecedented response, the DEA responded by withdrawing their intent to schedule, citing an effort to gather additional scientific information and to accept public comment. Over the next 6 weeks, more than 23,000 people submitted comments; over 99% expressed support for keeping kratom legal.

On November 14, 2017, the US Food and Drug Administration (FDA), citing their science-based obligation to the public, issued an advisory warning of “deadly risks” associated with kratom use, listing 36 deaths (later increased to 44) “associated with the use of kratom-containing products.” The FDA also warned of the risk for harm from adulterated kratom products and serious side effects including seizures, liver damage, and addiction.

Full article at Medscape

Bad Science: FDA Cla
Investigating The 'k
Rate This Article: